Does serotonin reuptake inhibitor therapy increase the risk of post-sphincterotomy bleeding in patients undergoing endoscopic retrograde cholangio-pancreatography?

Divya Yadav; John Vargo; Rocio Lopez; Prabhleen Chahal

doi:10.4253/wjge.v9.i4.171

Does serotonin reuptake inhibitor therapy increase the risk of post-sphincterotomy bleeding in patients undergoing endoscopic retrograde cholangio-pancreatography?

World J Gastrointest Endosc. 2017 Apr 16;9(4):171-176. doi: 10.4253/wjge.v9.i4.171.

Authors

Divya Yadav¹, John Vargo¹, Rocio Lopez¹, Prabhleen Chahal¹

Affiliation

¹ Divya Yadav, John Vargo, Prabhleen Chahal, Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, United States.

Abstract

Aim: To evaluate the risk of immediate and delayed bleeding following sphincterotomy procedure.

Methods: This retrospective cohort study was conducted with all patients who underwent endoscopic sphincterotomy during January 2006 to September 2015 at a tertiary academic center. Patients were grouped according to pre procedural usage of serotonin reuptake inhibitors (SRIs). Both groups were matched for demographic and clinical characteristics. Patients with thrombocytopenia, increased international normalized ratio, or a history of bleeding or coagulation disorders, concurrent use of other antiplatelet/anticoagulants were excluded from the study.

Results: A total of 447 patients were included, of which 219 (45.9%) used SRIs and 228 (54.1%) cases did not. There was no significant difference in acute or delayed bleeding during endoscopic sphincterotomy between the two groups. (8.2% vs 12.3%, P = 0.16).

Conclusion: The use of SRIs was not associated with an increased risk of post-sphincterotomy bleeding. To our best knowledge, this is the first study to explore this association.

Keywords: Endoscopic retrograde cholangiopancreatography; Endoscopy; Gastrointestinal bleeding; Post- sphincterotomy bleeding; Serotonin reuptake inhibitors.